IP Library Granted Patent US 9,908,870
Granted Patent B2
US 9,908,870 · App. 15/543,941 · Granted Mar 6, 2018

Crystalline form of a benzimidazole derivative and a preparation method thereof

Inventors: Young Ju Kim (Gyeonggi-do, KR); Eun Sun Kim (Gyeonggi-do, KR); Ji Yun Lee (Gyeonggi-do, KR); Hyuk Woo Lee (Gyeonggi-do, KR); Jae Hong Kweon (Gyeonggi-do, KR); Sung Ah Lee (Gyeonggi-do, KR); Kwang Do Choi (Gyeonggi-do, KR); Dong Hyun Ko (Gyeonggi-do, KR); Seung Pyeong Heo (Seoul, KR)
Assignee: CJ HEALTHCARE CORPORATION
C07D405/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,908,870
App. No.
15/543,941
Granted
Mar 6, 2018
Kind
B2
Abstract

The present invention relates to a novel crystalline form of a benzimidazole derivative and a preparation method thereof. The novel crystalline form according to the present invention is hardly changed chemically and/or physically under a long-term photo-stressed condition, has a low hygroscopicity, and has an extremely low static-electricity-inducing capability, thus being advantageous for formulation, and due to the excellent stability of the crystal form itself, it is very useful for long-term storage of the compound.

Claims (17)

1. A crystalline form A of a compound represented by the following Formula 1 having an X-ray powder diffraction pattern with peaks at diffraction angles of 8.1°, 10.0°, 12.6°, 14.9°, 15.6°, 16.5°, 17.2°, 19.6°, 23.1°, 24.2°, 28.1°, 30.2°, and 31.6° (2θ±0.2°):

2. The crystalline form A of claim 1 , wherein the crystalline form A has an endothermal peak at a temperature between 220° C. and 225° C. in differential scanning calorimetry.

3. The crystalline form A of claim 1 , wherein the crystalline form A has an IR spectrum with characteristic absorption peaks at 832 cm −1 , 1071 cm −1 , 1127 cm −1 , 1326 cm −1 , 1403 cm −1 , 1440 cm −1 , 1598 cm −1 , 2934 cm −1 , 3062 cm −1 , and 3124 cm −1 .

4. A method of preparing a crystalline form A of a compound represented by the following Formula 1, comprising:

suspending the compound represented by Formula 1 in any random form in a solvent selected from the group consisting of acetonitrile, C 1-4 alkylacetate, C 1-4 dichloroalkane, chloroform, tetrahydrofuran, toluene, di(C 1-4 alkyl)ether, (C 1-4 alkyl)(C 1-4 alkyl)ether, C 1-4 alkyl ether, water and a mixture thereof;

subjecting the resulting solution to heat-treatment while stirring for 1 hour to 24 hours; and

cooling the resulting solution to room temperature followed by ripening crystals while stirring for 1 hour to 48 hours:

5. The method of claim 4 , wherein the solvent is acetonitrile, methyl acetate, ethyl acetate, isopropyl acetate, 1,2-dichloroethane, methylene chloride, chloroform, tetrahydrofuran, toluene, diethyl ether, isopropyl ether, tert-butyl methyl ether, water or a mixture thereof.

6. The method of claim 4 , wherein the heat-treatment is to increase the temperature up to from 50° C. to 120° C.

7. A method of preparing a crystalline form A of a compound represented by the following Formula 1, comprising:

dissolving the compound represented by Formula 1 in any random form in a solvent selected from the group consisting of C 1-4 alcohol, acetone, and a mixture thereof;

crystallizing the compound by adding an antisolvent to the resulting solution; and

ripening the resulting crystal while stirring for 6 hours to 24 hours at room temperature:

8. The method of claim 7 , wherein the solvent is methanol, ethanol, isopropanol, n-propanol, n-butanol, isobutanol, t-butanol, acetone, or a mixture thereof.

9. The method of claim 7 , wherein the antisolvent is water, isopropyl ether, acetonitrile, diethyl ether, tert-butyl methyl ether, or a mixture thereof.

10. The method of claim 4 , further comprising filtering or drying.

11. The method of claim 7 , further comprising filtering or drying.

Assignments (2)
CHANGE OF NAME Recorded May 27, 2020
From: CJ HEALTHCARE CORPORATION
To: HK INNO.N CORPORATION
Reel/Frame 052768/0973 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2018
From: KIM, YOUNG JU; KIM, EUN SUN; LEE, JI YUN; LEE, HYUK WOO; KWEON, JAE HONG; LEE, SUNG AH; CHOI, KWANG DO; KO, DONG HYUN; HEO, SEUNG PYEONG
To: CJ HEALTHCARE CORPORATION
Reel/Frame 044668/0866 →
Priority Claims (1)
KR 10-2015-0009326 · Jan 20, 2015 · national
Continuity (1)
Related Publication 20180009791A1 · Jan 11, 2018